News Daily News TAVI and Complex/High-Risk PCI Safer if Staged, Registry Confirms Caitlin E. Cox April 28, 2025
News Features What’s in a Name: Is It Time to Choose Between TAVI and TAVR? Yael L. Maxwell March 27, 2025
News Conference News STS 2025 Surgery Outdoes Percutaneous Treatment for Patients With CAD, Aortic Stenosis Yael L. Maxwell February 05, 2025
News Daily News Some Guidance for Managing Patients With AS and CAD: Review Yael L. Maxwell December 24, 2024
News Conference News TCT 2024 Co-STAR Hints That Colchicine May Curb Rhythm Disturbances After TAVI Michael O'Riordan November 06, 2024
News Conference News TCT 2024 After TAVI, Single Antiplatelet Better Than Dual: TRITAVI Registry Yael L. Maxwell November 05, 2024
News Conference News TCT 2024 TAVR UNLOAD: No Rush to Do TAVI in HFrEF Patients With Moderate AS Todd Neale October 28, 2024
News Conference News ESC 2024 NOTION-3: PCI Before TAVI Lowers MACE Risks in Patients With Significant CAD Michael O'Riordan September 01, 2024
News Daily News Evolut TAVI Shows Promise in Low-risk Bicuspid Patients at 3 Years Yael L. Maxwell July 22, 2024
News Conference News NY Valves 2024 Reassuring 5-Year Outcomes for Sapien-Treated TAVI Patients With Small Annuli Michael O'Riordan June 05, 2024
News Conference News EuroPCR 2024 Coronary Access More Challenging With Self-Expanding Valves: SCAAR/SWENTRY Michael O'Riordan May 17, 2024
News Conference News EuroPCR 2024 ShortCut Leaflet Splitter Proves Safe, May Streamline Valve-in-Valve TAVI Shelley Wood May 16, 2024
News Conference News EuroPCR 2024 Debate Continues on TAVI Choice for Women With Small Annuli Yael L. Maxwell May 14, 2024
News Conference News EuroPCR 2024 NOW PUBLISHED - Latest TAVI vs Surgery Trial Raises Eyebrows in Aortic Stenosis Plus CAD Michael O'Riordan May 14, 2024
News Conference News STS 2024 Isolated vs Concomitant SAVR Offer Similar 5-Year Outcomes: PARTNER 3 Yael L. Maxwell February 09, 2024
News Daily News Obstructive CAD Can Be Left Alone Before TAVI, Observational Data Suggest Michael O'Riordan January 30, 2024